Tag: Oncology

Takeda signs licensing deal for Hutchmed’s fruquintinib outside of China

Raghuram Kadari- January 24, 2023

Takeda Pharmaceutical will acquire an exclusive worldwide license, excluding China, of fruquintinib from Hutchmed (China) and its subsidiary Hutchmed to strengthen its oncology portfolio. Under ... Read More

Seagen gets FDA accelerated approval for tucatinib, trastuzumab combo for colorectal cancer

Raghuram Kadari- January 21, 2023

American biotechnology company Seagen (formerly Seattle Genetics) has received accelerated approval from the US Food and Drug Administration (FDA) for the company’s oral drug Tukysa ... Read More

Regeneron gets Libtayo approval in Japan for advanced cervical cancer

Raghuram Kadari- December 31, 2022

Regeneron Pharmaceuticals has secured the approval of the Japanese Ministry of Health, Labor and Welfare (MHLW) to manufacture and market the company’s Libtayo (cemiplimab) for ... Read More

Merck and Mersana Therapeutics to co-develop new immunostimulatory ADCs

Raghuram Kadari- December 29, 2022

Merck has announced a collaboration with US-based Mersana Therapeutics to discover new antibody-drug conjugates (ADCs) by leveraging the latter’s proprietary Immunosynthen STING-agonist ADC platform. The ... Read More

AstraZeneca to acquire cell therapy company Neogene Therapeutics

Raghuram Kadari- December 1, 2022

AstraZeneca will acquire Neogene Therapeutics, a US-based clinical-stage biotechnology company, for a total consideration of up to $320 million, bringing next-generation transformative cell therapies for ... Read More

Lupin subsidiary MedQuímica buys rights to nine drugs from Bausch Health

businessnewstoday- November 29, 2022

Lupin Limited said that MedQuímica Indústria Farmacêutica, its 100% subsidiary in Brazil, has agreed to acquire all rights to nine drugs from Bausch Health Companies’ ... Read More

Alembic Pharmaceuticals gets FDA final approval for Paclitaxel Injection USP

businessnewstoday- October 27, 2022

Alembic Pharmaceuticals Limited has secured final approval for its abbreviated new drug application (ANDA) for Paclitaxel Injection USP, 30 mg/5 mL (6 mg/mL), 100 mg/16.7 ... Read More

Clinical-stage pharma firms Ayala Pharmaceuticals, Advaxis sign merger deal

businessnewstoday- October 22, 2022

Ayala Pharmaceuticals, a Nasdaq-listed clinical-stage oncology company, has entered into a merger deal with New Jersey-based biotech company Advaxis. Based in Delaware, Ayala Pharmaceuticals is ... Read More

LG Chem to acquire US biotech company Aveo Oncology for $566m

Raghuram Kadari- October 18, 2022

LG Chem acquisition of Aveo Oncology : South Korea’s LG Chem has entered into a definitive agreement to acquire Aveo Oncology, a US-based biotech company, ... Read More

Gilead gets Trodelvy FDA priority review for pre-treated HR+/HER2- metastatic breast cancer

businessnewstoday- October 16, 2022

Gilead Sciences said that Trodelvy (sacituzumab govitecan-hziy) has been granted priority review from the US Food and Drug Administration (FDA) for the treatment of another ... Read More